From low remission to hope: the efficacy of targeted therapies in NUP98-R positive pediatric acute myeloid leukemia
This study demonstrated that using targeted drugs for the induction in NUP98-R pediatric AML improved treatment outcomes. BCL-2, FLT3, and CDK6 inhibitors available at our institution are promising options for this phase of treatment.
Authors
- Runming Jin
- Hui-Yi Pan
- Ran Xiong (ORCID: https://orcid.org/0000-0002-3512-8851)
- Hongxia Tang (ORCID: https://orcid.org/0000-0003-3386-1854)
- Tiantian Yin (ORCID: https://orcid.org/0000-0003-1529-1085)
Institutions
- Union Hospital (CN)
- Huazhong University of Science and Technology (CN)
Publication Details
- Journal
- World Journal of Pediatrics
- Published
- 2025-02-27
- DOI
- https://doi.org/10.1007/s12519-025-00875-w
- Citations
- 1
- Primary Topic
- Acute Myeloid Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 1.77
Funders
- Wuhan Union Hospital